Experience with the Atrium Advanta covered stent for aortic obstruction

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Pediatric Cardiology

Background:

• Coarctation of the aorta (CoA) is a congenital heart defect requiring effective management.
• The Advanta V12™ covered stent is a potential therapeutic option for CoA.

Purpose of the Study:

• To evaluate the efficacy, safety, and clinical outcomes of the Advanta V12™ covered stent in managing coarctation of the aorta.

Main Methods:

• Retrospective review of 17 patients who underwent Advanta V12™ stent implantation for CoA.
• Assessment included angiographic imaging, clinical data, chest roentgenograms, radiation exposure, and complications.
• Clinical outcomes were evaluated at admission, discharge, and latest follow-up (median 242 days).

Main Results:

• Significant improvement in aortic diameter (6.6 to 11.5 mm) and reduction in peak pressure gradient (23.1 to 0.8 mmHg) were observed (P<0.0001).
• No symptomatic complications occurred; blood pressure gradients normalized post-implantation (P<0.0001).
• While 18% required reintervention and 33% initially needed antihypertensives, long-term outcomes were stable.

Conclusions:

• Advanta V12™ stent implantation demonstrates early safety and effectiveness in treating coarctation of the aorta.
• The procedure led to significant hemodynamic improvements and was well-tolerated in the short term.
• Longer-term efficacy of the Advanta V12™ stent for CoA requires further investigation.